In 2011 Bravo Pharma was established and since then he is working to expand the healthcare business globally.  The corporate affairs of Bravo Group are being closely looked after by Rakesh, which includes identifying the business avenues in United Kingdom, India, Central Asia, Europe, USA, Africa, South East Asia, Middle East and Russia. 

Bravo Pharma is a group of companies focused on drug development; R&D in the specialised fields like oncology, HIV-Self test, COVID Test and liver diseases; manufacturing, marketing and sales of medical products; telemedicine and advance diagnostics cum referral laboratory.  Currently Bravo Pharma has activities in 8 countries spread across Asia, Africa, Middle East and Europe.

Rakesh has been working closely with the John’s Hopkins Cancer Hospital Baltimore USA, Harlev Hospitals Denmark, financed the on-going cancer research programme for the development of the Biomarkers for pancreatic cancer. He has also established the Joint cooperation with NEC, Ministry of Defence Uganda, and ministry of police reform Uganda, for the development of e-healthcare platform for central Africa.

He also helped in set up of the first Referral Laboratory specialised in Oncological research and clinical trial in the Republic Oncology Hospital, Uzbekistan on BOT basis.

He also runs BRAVO Foundation which is an independent organization set up by the Bravo Pharma Group to facilitate public-private funded initiatives to improve the welfare of the Youth of Bihar specially focused on the employment for youth, Education and Healthcare across the Bihar and specially Champaran.